PCA3 May Help Predict Insignificant Prostate Cancer
- Prostate cancer gene 3 (PCA3) may be a valuable predictor of pathologically confirmed low volume disease and insignificant prostate cancer (PCa)
- PCA3 urine test may be a good predictor of low-volume disease and may have a future role in managing patients on active surveillance protocols.
- “When you shed PCA3 cells in the urine you can get a PCA3 score and that means if you have a cancer in your prostate you will have a higher quantity of PCA3”
- “If what is sloughed off in the urine is reflective of what is happening in the prostate it would have tremendous application in not just in detecting cancer but also in monitoring patients who are now subjected to serial biopsies”
- The PCA3 test is approved in Europe and its approval is being considered by the FDA.
No comments:
Post a Comment